1. Home
  2. MDAIW vs LOMA Comparison

MDAIW vs LOMA Comparison

Compare MDAIW & LOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAIW
  • LOMA
  • Stock Information
  • Founded
  • MDAIW N/A
  • LOMA 1926
  • Country
  • MDAIW United States
  • LOMA Argentina
  • Employees
  • MDAIW 78
  • LOMA N/A
  • Industry
  • MDAIW Medical/Dental Instruments
  • LOMA Building Materials
  • Sector
  • MDAIW Health Care
  • LOMA Industrials
  • Exchange
  • MDAIW Nasdaq
  • LOMA Nasdaq
  • Market Cap
  • MDAIW N/A
  • LOMA N/A
  • IPO Year
  • MDAIW N/A
  • LOMA 2017
  • Fundamental
  • Price
  • MDAIW $0.31
  • LOMA $11.51
  • Analyst Decision
  • MDAIW
  • LOMA Strong Buy
  • Analyst Count
  • MDAIW 0
  • LOMA 1
  • Target Price
  • MDAIW N/A
  • LOMA $14.00
  • AVG Volume (30 Days)
  • MDAIW 35.6K
  • LOMA 325.7K
  • Earning Date
  • MDAIW 02-27-2025
  • LOMA 05-20-2025
  • Dividend Yield
  • MDAIW N/A
  • LOMA N/A
  • EPS Growth
  • MDAIW N/A
  • LOMA 107.95
  • EPS
  • MDAIW N/A
  • LOMA 0.77
  • Revenue
  • MDAIW $27,264,000.00
  • LOMA $636,700,194.00
  • Revenue This Year
  • MDAIW N/A
  • LOMA N/A
  • Revenue Next Year
  • MDAIW N/A
  • LOMA N/A
  • P/E Ratio
  • MDAIW N/A
  • LOMA $14.99
  • Revenue Growth
  • MDAIW 44.52
  • LOMA 83.83
  • 52 Week Low
  • MDAIW $0.08
  • LOMA $5.70
  • 52 Week High
  • MDAIW $0.90
  • LOMA $13.79
  • Technical
  • Relative Strength Index (RSI)
  • MDAIW N/A
  • LOMA 55.34
  • Support Level
  • MDAIW N/A
  • LOMA $10.83
  • Resistance Level
  • MDAIW N/A
  • LOMA $11.81
  • Average True Range (ATR)
  • MDAIW 0.00
  • LOMA 0.52
  • MACD
  • MDAIW 0.00
  • LOMA 0.02
  • Stochastic Oscillator
  • MDAIW 0.00
  • LOMA 56.28

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: